Valuation: Amgen Inc.

Market Cap 195B 170B 156B 146B 277B 18,565B 281B 1,884B 730B 9,106B 732B 716B 31,377B P/E 2026 *
23.5x
P/E 2027 * 21.7x
Enterprise Value 237B 207B 190B 177B 336B 22,536B 341B 2,287B 886B 11,053B 889B 870B 38,087B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 5.97x
Free-Float
99.78%
Yield 2026 *
2.79%
Yield 2027 * 2.95%
1 day+3.12%
1 week+5.24%
Current month+2.54%
1 month+13.12%
3 months+6.72%
6 months+13.33%
Current year+13.45%
1 week 354.16
Extreme 354.16
375.15
1 month 325.98
Extreme 325.98
375.15
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.12%+5.24%+25.09%+65.03% 195B
+1.69%+7.43%+55.46%+162.55% 1,063B
+3.20%+6.88%+68.25%+60.23% 611B
+3.45%+6.83%+36.17%+92.39% 444B
+4.17%-0.96%+26.12%+20.22% 324B
+4.94%+3.39%+39.92%+40.14% 285B
+2.42%+1.60%+30.06%+44.59% 283B
+2.47%+5.18%-24.80%-38.67% 219B
+3.38%+5.00%+16.61%+69.50% 156B
+1.74%+2.64%-4.05%-33.71% 136B
Average +3.14%+2.29%+26.88%+48.23% 371.68B
Weighted average by Cap. +2.93%+3.91%+39.44%+78.48%

Financials

2026 *2027 *
Net sales 37.76B 33B 30.3B 28.26B 53.57B 3,595B 54.47B 365B 141B 1,763B 142B 139B 6,076B 38.71B 33.83B 31.06B 28.97B 54.92B 3,686B 55.84B 374B 145B 1,808B 145B 142B 6,229B
Net income 8.23B 7.19B 6.6B 6.16B 11.68B 784B 11.87B 79.52B 30.82B 384B 30.91B 30.24B 1,324B 8.86B 7.75B 7.11B 6.63B 12.58B 844B 12.79B 85.64B 33.19B 414B 33.29B 32.56B 1,426B
Net Debt 41.7B 36.44B 33.46B 31.21B 59.16B 3,970B 60.16B 403B 156B 1,947B 157B 153B 6,710B 36.06B 31.51B 28.93B 26.98B 51.15B 3,433B 52.01B 348B 135B 1,684B 135B 132B 5,802B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-02 $371.33 +2.77% 883,791
26-07-01 $361.33 -0.22% 2,244,791
26-06-30 $362.12 +0.44% 2,246,908
26-06-29 $360.55 +0.62% 2,461,887
26-06-26 $358.33 +1.56% 3,610,561
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
361.33USD
Average target price
354.76USD
Spread / Average Target
-1.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock